601117:SSEChina National Chemical Engineering Co., Ltd Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥9.35
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
China National Chemical Engineering (601117.SS) is trading at CNY 9.35, comfortably above its 20‑day (9.13), 50‑day (8.63) and 200‑day (7.98) moving averages, confirming a bullish price trend. The MACD line (0.30) sits above its signal (0.28) and the histogram is positive, while the RSI of 54.9 indicates the stock is not yet overbought. Valuation metrics are compelling: a trailing P/E of 9.4 is far below the industry average of 29.4, and the price‑to‑book of 0.87 suggests a discount to net assets. The discounted cash‑flow model places fair value at CNY 16.94, implying a ~45% upside from current levels. A 3% dividend yield with an 18.8% payout ratio points to a sustainable income stream, supported by strong cash generation (operating cash flow CNY 8.78 bn) and a low debt‑to‑equity of 18.9%.
Volatility is elevated at 44.9% over the past 30 days, but the stock’s beta of 0.12 indicates minimal market‑wide risk exposure. Volume is rising, reinforcing the technical strength, and the price sits above the near‑term support of CNY 8.31 with resistance near CNY 10.48, offering a clear upside corridor. The company’s modest revenue growth (4.3%) and thin margins reflect a value‑oriented profile rather than high‑growth, aligning with the strong dividend and low‑leverage fundamentals. Overall, the confluence of cheap valuation, solid cash flow, and bullish technical signals makes the stock attractive across horizons.
Volatility is elevated at 44.9% over the past 30 days, but the stock’s beta of 0.12 indicates minimal market‑wide risk exposure. Volume is rising, reinforcing the technical strength, and the price sits above the near‑term support of CNY 8.31 with resistance near CNY 10.48, offering a clear upside corridor. The company’s modest revenue growth (4.3%) and thin margins reflect a value‑oriented profile rather than high‑growth, aligning with the strong dividend and low‑leverage fundamentals. Overall, the confluence of cheap valuation, solid cash flow, and bullish technical signals makes the stock attractive across horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above all major moving averages
- Bullish MACD and rising volume
- Support level provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Sustainable 3% dividend yield
- Low leverage and strong operating cash flow
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- State‑owned enterprise with stable government contracts
- Consistently low valuation multiples versus peers
- Robust balance sheet and modest debt profile
Key Metrics & Analysis
Financial Health
Revenue Growth4.30%
Profit Margin3.24%
P/E Ratio9.4
ROE9.53%
ROA1.96%
Debt/Equity18.85
P/B Ratio0.9
Op. Cash FlowCN¥8.8B
Free Cash FlowCN¥4.8B
Industry P/E29.4
Technical Analysis
TrendBullish
RSI54.9
SupportCN¥8.31
ResistanceCN¥10.48
MA 20CN¥9.13
MA 50CN¥8.62
MA 200CN¥7.98
MACDBullish
VolumeIncreasing
Fear & Greed Index81
Valuation
Fair ValueCN¥16.94
GradeUndervalued
TypeValue
Dividend Yield3.00%
Risk Assessment
Beta0.12
Volatility44.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.